Evidence map›Paper›PMID 26962013›Full record

Trial reportThorax2016

Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial).

M Chatwin, G Hawkins, L Panicchia, A Woods, A Hanak, R Lucas, E Baker, E Ramhamdany, B Mann, J Riley and 2 more

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Thorax, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 49 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02180919 phase1completednot on this map

Implementation of Telemonitoring in the Management of Acute Exacerbations of Chronic Heart Failure and Respiratory Failure/Chronic Obstructive Pulmonary Disease

TypeinterventionalSponsorRoyal Brompton & Harefield NHS Foundation TrustRan2010 to 2012Enrolled85ConditionsCOPD, Heart Failure, Respiratory FailureArmsCE marked Philips Motiva system
NCT04946708 nacompletednot on this mapstarted 2021, after this paper: background citation

Using Technology to Engage Patients With Interstitial Lung Disease (ILD) in a Home a Home Exercise Program.

TypeinterventionalSponsorUniversity of ManitobaRan2021 to 2022Enrolled14ConditionsInterstitial Lung DiseaseArmsExercise program (virtual/remote)
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Review
  14. Article
  15. Review
  16. Clinical review of non-invasive ventilation.The European respiratory journal · 2024
    Review
  17. The role of telemonitoring in patients on home mechanical ventilation.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  18. Quality of life in patients with chronic respiratory failure on home mechanical ventilation.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

M Chatwin
G Hawkins
L Panicchia
A Woods
A Hanak
R Lucas
E Baker
E Ramhamdany
B Mann
J Riley
M R Cowie
A K Simonds

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

designRandomised crossover trial with 6 months of standard best practice clinical care (control group) and 6 months with the addition of telemonitoring.

participants68 patients with chronic lung disease (38 with COPD; 30 with chronic respiratory failure due to other causes), who had a hospital admission for an exacerbation within 6 months of randomisation and either used long-term oxygen therapy or had an arterial oxygen saturation (SpO2) of <90% on air during the previous admission. Individuals received telemonitoring (second-generation system) via broadband link to a hospital-based care team. OUTCOME MEASURES: Primary outcome measure was time to first hospital admission for an acute exacerbation. Secondary outcome measures were hospital admissions, general practitioner (GP) consultations and home visits by nurses, quality of life measured by EuroQol-5D and hospital anxiety and depression (HAD) scale, and self-efficacy score (Stanford).

resultsMedian (IQR) number of days to first admission showed no difference between the two groups—77 (114) telemonitoring, 77.5 (61) control ( p=0.189). Hospital admission rate at 6 months increased (0.63 telemonitoring vs 0.32 control p=0.026). Home visits increased during telemonitoring; GP consultations were unchanged. Self-efficacy fell, while HAD depression score improved marginally during telemonitoring.

conclusionsTelemonitoring added to standard care did not alter time to next acute hospital admission, increased hospital admissions and home visits overall, and did not improve quality of life in chronic respiratory patients. TRIAL REGISTRATION NUMBER: NCT02180919 (ClinicalTrials.gov).

Indexed as

Oxygen Inhalation TherapyTelemedicineAgedChronic DiseaseCross-Over StudiesFemaleHumansMaleMiddle AgedPulmonary Disease, Chronic ObstructiveQuality of LifeRespiratory InsufficiencyRisk FactorsTreatment Outcome

Identifiers

PMID26962013
PMCPMC4819626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.